Antiplatelet Therapy and Bleeding Outcomes With CYP2C19 Genotyping

• Autores principales: James C. Coons PharmD (Autor), James M. Stevenson PharmD, MS (Autor), Ami Patel PharmD (Autor), A. J. Conrad Smith MD (Autor), Linda Prebehalla BSN, RN (Autor), Philip E. Empey PharmD, PhD (Autor)
• Formato: Libro
• Publicado: SAGE Publishing, 2022-12-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Purpose: The impact of antiplatelet therapy with availability of CYP2C19 genotyping on bleeding in a real-world setting has not been extensively studied. Methods: Prospective, single-center, cohort study conducted between December 2015 and October 2019 with 1-year follow-up. Patients underwent percu...